These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 9516378

  • 1. Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer.
    Broxmeyer HE, Orazi A, Hague NL, Sledge GW, Rasmussen H, Gordon MS.
    Blood Cells Mol Dis; 1998 Mar; 24(1):14-30. PubMed ID: 9516378
    [Abstract] [Full Text] [Related]

  • 2. Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.
    Cooper S, Mantel C, Broxmeyer HE.
    Exp Hematol; 1994 Feb; 22(2):186-93. PubMed ID: 8299739
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
    Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3448-58. PubMed ID: 7682242
    [Abstract] [Full Text] [Related]

  • 4. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha.
    Maze R, Sherry B, Kwon BS, Cerami A, Broxmeyer HE.
    J Immunol; 1992 Aug 01; 149(3):1004-9. PubMed ID: 1634758
    [Abstract] [Full Text] [Related]

  • 5. MIP-1alpha and TGF-beta production in CD34+ progenitor-stromal cell coculture systems: effects of progenitor isolation method and cell-cell contact.
    Liesveld JL, Harbol AW, Belanger T, Rosell KE, Abboud CN.
    Blood Cells Mol Dis; 2000 Aug 01; 26(4):261-75. PubMed ID: 11042027
    [Abstract] [Full Text] [Related]

  • 6. Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells.
    de Wynter EA, Durig J, Cross MA, Heyworth CM, Testa NG.
    Stem Cells; 1998 Aug 01; 16(5):349-56. PubMed ID: 9766815
    [Abstract] [Full Text] [Related]

  • 7. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr 01; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 8. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth.
    Broxmeyer HE, Sherry B, Cooper S, Ruscetti FW, Williams DE, Arosio P, Kwon BS, Cerami A.
    J Immunol; 1991 Oct 15; 147(8):2586-94. PubMed ID: 1918979
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H, Little MT, Dragowska W, Thornbury G, Lansdorp PM.
    Exp Hematol; 1995 May 15; 23(5):422-7. PubMed ID: 7536684
    [Abstract] [Full Text] [Related]

  • 10. Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C.
    Broxmeyer HE, Pelus LM, Kim CH, Hangoc G, Cooper S, Hromas R.
    Exp Hematol; 2006 Aug 15; 34(8):1069-77. PubMed ID: 16863913
    [Abstract] [Full Text] [Related]

  • 11. Short-term, serum-free, static culture of cord blood-derived CD34+ cells: effects of FLT3-L and MIP-1alpha on in vitro expansion of hematopoietic progenitor cells.
    Capmany G, Querol S, Cancelas JA, García J.
    Haematologica; 1999 Aug 15; 84(8):675-82. PubMed ID: 10457401
    [Abstract] [Full Text] [Related]

  • 12. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P, Cornetta K, Davidson A, Agüero B, McMahel J, Traycoff CM, Srour EF.
    Bone Marrow Transplant; 1997 Jun 15; 19(12):1213-21. PubMed ID: 9208115
    [Abstract] [Full Text] [Related]

  • 13. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
    Karlic H, Louda N, Pfeilstöcker M, Keil F, Lohninger A, Pittermann E, Paukovits J.
    Stem Cells; 2001 Jun 15; 19(4):321-8. PubMed ID: 11463952
    [Abstract] [Full Text] [Related]

  • 14. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
    Holyoake TL, Freshney MG, Sproul AM, Richmond LJ, Alcorn MJ, Steward WP, Fitzsimons E, Dunlop DJ, Franklin IM, Pragnell IB.
    Stem Cells; 1993 Oct 15; 11 Suppl 3():122-8. PubMed ID: 8298472
    [Abstract] [Full Text] [Related]

  • 15. Macrophage inflammatory protein-1 alpha enhances growth factor-stimulated phosphatidylcholine metabolism and increases cAMP levels in the human growth factor-dependent cell line M07e, events associated with growth suppression.
    Mantel C, Aronica S, Luo Z, Marshall MS, Kim YJ, Cooper S, Hague N, Broxmeyer HE.
    J Immunol; 1995 Mar 01; 154(5):2342-50. PubMed ID: 7532666
    [Abstract] [Full Text] [Related]

  • 16. CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.
    Weekx SF, Van Bockstaele DR, Plum J, Moulijn A, Rodrigus I, Lardon F, De Smedt M, Nijs G, Lenjou M, Loquet P, Berneman ZN, Snoeck HW.
    Exp Hematol; 1998 Oct 01; 26(11):1034-42. PubMed ID: 9766443
    [Abstract] [Full Text] [Related]

  • 17. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 01; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 18. Macrophage-inflammatory protein-1alpha receptor expression on normal and chronic myeloid leukemia CD34+ cells.
    Nicholls SE, Lucas G, Graham GJ, Russell NH, Mottram R, Whetton AD, Buckle AM.
    J Immunol; 1999 May 15; 162(10):6191-9. PubMed ID: 10229864
    [Abstract] [Full Text] [Related]

  • 19. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.
    Kiss J, Kunstár A, Fajka-Boja R, Dudics V, Tóvári J, Légrádi A, Monostori E, Uher F.
    Exp Hematol; 2007 Feb 15; 35(2):305-13. PubMed ID: 17258079
    [Abstract] [Full Text] [Related]

  • 20. Abl protein kinase abrogates the response of multipotent haemopoietic cells to the growth inhibitor macrophage inflammatory protein-1 alpha.
    Wark G, Heyworth CM, Spooncer E, Czaplewski L, Francis JM, Dexter TM, Whetton AD.
    Oncogene; 1998 Mar 12; 16(10):1319-24. PubMed ID: 9546433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.